Department of Oncology, Xijing Hospital, State Key Discipline of Cell Biology, Fourth Military Medical University, Xi'an, China.
Cancer. 2012 Sep 1;118(17):4105-16. doi: 10.1002/cncr.27393. Epub 2012 Jan 3.
Tumor neovascularization (TNV) is a common pathologic basis for malignant growth and metastasis. However, the mechanism of TNV pathogenesis is not fully understood. Ras homolog gene family, member A (RhoA), a Rho guanosine triphosphatase (GTPase) family member, may be involved in a hypoxia-induced vascular endothelial growth factor (VEGF) pathway that regulates TNV angiogenesis through an unclear mechanism.
The regulation of RhoA on p53, the p53 binding protein homolog murine double minute 2 (MDM2), and VEGF was analyzed in hypoxic MCF-7 cells using Western blot analysis, real-time polymerase chain reaction (PCR) analysis, coimmunoprecipitation, and immunofluorescence staining assays. Changes in proliferation, invasion, migration, stress fiber formation, and tube formation were detected in an MCF-7 human umbilical vein endothelial cell (HUVEC) coculture system. Correlations of RhoA expression with MDM2, wild-type p53 (wt-p53), and VEGF expression in breast cancer tissues and relations between RhoA and breast cancer clinical features were analyzed by immunohistochemistry.
Activated RhoA down-regulated p53 protein, which increased VEGF expression in hypoxic MCF-7 cells; whereas p53 messenger RNA levels were not altered. In addition, the ubiquitin-mediated degradation of p53 was enhanced by active RhoA. RhoA and MDM2 colocalized in the cytoplasm of hypoxic MCF-7 cells and interacted with each other physically. Furthermore, nutlin-3, a specific MDM2 inhibitor, was capable of reducing activated RhoA-induced p53 protein stability and attenuating VEGF accumulation. In an MCF-7-HUVEC coculture system, nutlin-3 effectively inhibited HUVEC proliferation, invasion, migration, stress fiber formation, and tube formation mediated by activated RhoA under hypoxic conditions. Data from 129 clinical breast cancer specimens with wt-p53 revealed that high RhoA expression was correlated with high MDM2 expression, low wt-p53 expression, and high VEGF expression.
The current data suggested that activated RhoA promotes VEGF expression and hypoxia-induced angiogenesis through the up-regulation of MDM2 to decrease p53 stability.
肿瘤新生血管(TNV)是恶性生长和转移的常见病理基础。然而,TNV 发病机制尚不完全清楚。Ras 同源基因家族成员 A(RhoA)是 Rho 鸟苷三磷酸酶(GTPase)家族成员,可能参与缺氧诱导的血管内皮生长因子(VEGF)通路,通过尚不清楚的机制调节 TNV 血管生成。
采用 Western blot 分析、实时聚合酶链反应(PCR)分析、共免疫沉淀和免疫荧光染色检测缺氧 MCF-7 细胞中 RhoA 对 p53、p53 结合蛋白同系物鼠双微体 2(MDM2)和 VEGF 的调控。在 MCF-7 人脐静脉内皮细胞(HUVEC)共培养系统中检测增殖、侵袭、迁移、应力纤维形成和管形成的变化。采用免疫组织化学分析 RhoA 表达与乳腺癌组织中 MDM2、野生型 p53(wt-p53)和 VEGF 表达的相关性,以及 RhoA 与乳腺癌临床特征的关系。
激活的 RhoA 下调 p53 蛋白,增加缺氧 MCF-7 细胞中 VEGF 的表达;而 p53 mRNA 水平没有改变。此外,活性 RhoA 增强了 p53 的泛素介导降解。在缺氧 MCF-7 细胞中,RhoA 和 MDM2 细胞质内共定位并相互作用。此外,特异性 MDM2 抑制剂 nutlin-3 能够减少激活的 RhoA 诱导的 p53 蛋白稳定性,并减弱 VEGF 的积累。在 MCF-7-HUVEC 共培养系统中,nutlin-3 可有效抑制缺氧条件下激活的 RhoA 介导的 HUVEC 增殖、侵袭、迁移、应力纤维形成和管形成。在 129 例 wt-p53 乳腺癌标本中发现,高 RhoA 表达与高 MDM2 表达、低 wt-p53 表达和高 VEGF 表达相关。
目前的数据表明,激活的 RhoA 通过上调 MDM2 降低 p53 稳定性,促进 VEGF 表达和缺氧诱导的血管生成。